AIDS & HIV
HIV Market Forecast
| Publication Date | June 2009 |
| Publisher | Datamonitor |
| Product Type | |
| Pages | not applicable |
| ISBN Number | not applicable |
| Product Code | DAT01775 |
Price
£10,040.00
approximately: $15,202 | €11,206
approximately: $15,202 | €11,206
Order above formats by FAX
Summary
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiation, decreasing mortality and an increase in HIV prevalence, a series of patent expiries will impact branded sales from 2011.
Reasons to Purchase
- Understand the changing market dynamics of HIV drugs, success factors for leading brands and the commercial potential of late stage pipeline products
- Assess the impact of events such as patent expiries and new product launches on individual brands and the overall antiretroviral market.
- Obtain full global, country, class and product-specific forecasts of currently marketed and pipeline antiretrovirals from 2008 to 2018.
